Knobelman Deborah
- SEC CIK
- 0001931509
No open-market purchases or sales filed in the past year.
Current role at each company
- KRON Kronos Bio, Inc.President & Interim CEOas of Jun 20, 2025
- SNTI Senti Biosciences Holdings, Inc.Chief Financial Officeras of Feb 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Knobelman Deborah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KRON Kronos Bio, Inc.
President & Interim CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 (view filing) | Jun 5 | 1 day | Knobelman DeborahPresident & Interim CEO | SSale | −24.8K | $0.87 | −$21.6K | −15.1%139.4K after |